Defining key terms

Within the regulation are seven key terms that the FDA has defined:
Closed system:
An environment in which system access is controlled by persons who are responsible for the content of electronic records that are on the system. This document assumes that a closed system is used.
Open system:
An environment in which system access is not controlled by persons who are responsible for the content of electronic records that are on the system.
Electronic record:
Any combination of text, graphics, data, audio, pictorial, or other information representation in digital form that is created, modified, maintained, archived, retrieved, or distributed by a computer system.
Biometrics:
A method of verifying an individual’s identity based on measurement of the individual’s physical feature(s) or repeatable action(s) where those features and/or actions are both unique to that individual and measurable.
Electronic signature:
A computer data compilation of any symbol or series of symbols, executed, adopted, or authorized by an individual to be the legally binding equivalent of the individual’s handwritten signature. 
Digital signature:
An electronic signature based on cryptographic methods of originator authentication, computed by using a set of rules and a set of parameters such that the identity of the signer and the integrity of the data can be verified.
Handwritten signature:
The scripted name or legal mark of an individual handwritten by that individual and executed or adopted with the present intention to authenticate a writing in a permanent form. The act of signing with a writing or marking instrument such as a pen or stylus is preserved. The scripted name or legal mark, while conventionally applied to paper, may also be applied to other devices that capture the name or mark.
Provide Feedback
Have questions or feedback about this documentation? Please submit your feedback here.